Holen Sie sich die Stockscreener-App
20.67
2.36%
-0.50
Scribe Therapeutics Inc. Common Stock Aktie (SCTX) Neueste Nachrichten
Scribe Therapeutics Inc. Common Stock (NASDAQ: SCTX) Stock Price, News & Analysis - kalkine.ca
Scribe Therapeutics Inc. Common Stock (NASDAQ: SCTX) Stock Price, News & Analysis - Kalkine
Scribe Therapeutics (SCTX) awards 14,725 stock options to director Bleharski - Stock Titan
OrbiMed Advisors Discloses Investment in Scribe Therapeutics with 7.2% Stake - TradingView
Scribe Therapeutics Completes Initial Public Offering and Private Placement - SynBioBeta
Scribe Therapeutics raises $155.51M in IPO on Nasdaq By Investing.com - Investing.com India
Avoro lifts Scribe (NASDAQ: SCTX) stake to 3.09M shares - Stock Titan
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO - Legal Desire
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO - Latham & Watkins LLP
Scribe Therapeutics IPO closes as Sanofi buys 500K shares - Stock Titan
Scribe Therapeutics, In Vivo CRISPR Genetic Medicines, Files for Nasdaq IPO - TradingView
Scribe Therapeutics Announces Closing of Initial Public - GlobeNewswire
Scribe Therapeutics Closes Upsized $155.5 Million IPO and Concurrent Private Placement with Sanofi - Quiver Quantitative
Scribe Therapeutics closes $155.5M IPO at $15 per share - Investing.com
Scribe Therapeutics raises $155.51M in IPO on Nasdaq - Investing.com
Scribe Therapeutics raises $155.51M in IPO on Nasdaq By Investing.com - Investing.com Nigeria
Scribe Therapeutics (SCTX) CFO gets major option grants and family share buys - Stock Titan
Scribe Therapeutics (SCTX) awards 14,725 stock options to director James Dean Watson - Stock Titan
Scribe Therapeutics (SCTX) grants 14,725 options to Aghazadeh and Avoro entities - Stock Titan
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement - Yahoo Finance
Scribe Therapeutics (SCTX) CEO receives time- and performance-based option grants - Stock Titan
Scribe Therapeutics prices IPO at $15 per share on Nasdaq By Investing.com - Investing.com UK
IPO calendar for: - Yahoo Finance Singapore
Scribe Therapeutics prices IPO at $15 per share on Nasdaq By Investing.com - Investing.com Nigeria
Scribe Therapeutics Prices Upsized $128.7 Million Initial Public Offering and Concurrent Private Placement to Sanofi - quiverquant.com
Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech - BioSpace
Scribe Therapeutics Inc. (SCTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Scribe Therapeutics (Nasdaq:SCTX)Stock Analysis - Simply Wall Street
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewswire
Scribe Therapeutics prices IPO at $15 per share on Nasdaq - Investing.com
Scribe Therapeutics Inc. has completed an IPO in the amount of $128.7 million. - marketscreener.com
Scribe Therapeutics prices IPO at $15, to raise $128.7M - Investing.com
Sanofi Agrees to Buy 500,000 Scribe Shares in a Private Placement - Stock Titan
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering - Yahoo Finance
Scribe Therapeutics Starts IPO Effort For CRISPR Pipeline Development (SCTX) - Seeking Alpha
Scribe Therapeutics files for 7.15M share IPO at $13-$15/sh - Investing.com
Scribe Therapeutics files for 7.15M share IPO at $13-$15/sh - Investing.com Nigeria
Scribe Therapeutics files for 7.15M share IPO at $13-$15/sh - Investing.com UK
1.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):